Mucosal melanoma
Clinical trials for Mucosal melanoma explained in plain language.
Never miss a new study
Get alerted when new Mucosal melanoma trials appear
Sign up with your email to follow new studies for Mucosal melanoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive drug targets Hard-to-Treat melanoma in early trial
Disease control Stopped earlyThis early-stage trial tests a radioactive drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or can't be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants receive the drug every 6 weeks for up to 6 doses, an…
Matched conditions: MUCOSAL MELANOMA
Phase 1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can an immune checkpoint blocker outperform interferon in keeping mucosal melanoma at bay?
Disease control Stopped earlyThis phase II trial tests whether toripalimab, an anti-PD-1 antibody, can prevent mucosal melanoma from returning after surgical removal better than high-dose interferon. Adults aged 18 to 75 whose melanoma was completely removed and who have not had prior adjuvant therapy are el…
Matched conditions: MUCOSAL MELANOMA
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC